Drug Approval | November 18, 2021
Zydus Cadila receives U.S.FDA approval for leukaemia injection
Nelarabine is in a class of medications called antimetabolites
Nelarabine is in a class of medications called antimetabolites
Branded and unbranded versions of the first-ever interchangeable biosimilar in the U.S. provide more affordable options for the millions of Americans living with diabetes
It is India’s first pneumotach based portable wireless Spirometer for diagnosis of Chronic Obstructive Pulmonary Disorder (COPD)
BRIDGE-1 Comprehensive care programme for Type 1 diabetes and to train 400 physicians and benefit over 1000 children
The start-up has announced the scheme to mark World Diabetes Day
Biocon Biologics and Viatris co-developed the products
The combined entity will have 12 hospitals with 3,666 beds
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Subscribe To Our Newsletter & Stay Updated
